Posted in | News | Imaging

BitFlow Secures CE Mark Approval for Axion-CL™ and Cyton-CXP™ Frame Grabbers

BitFlow today announced that it has secured CE (Conformité Européenne) Mark clearance for its Axion-CL and Cyton-CXP frame grabbers.

Setting the stage for the company to launch both to European Union customers who deploy Camera Link or CoaXPress based technology in machine vision, industrial automation and inspection, or medical design projects.

CE Mark approval is a very important milestone for BitFlow and validates the dedication of our engineering team to deliver innovative vision products of the highest quality. We are pleased to now be able to provide our European customers with these advanced imaging components. It is an important step in achieving our vision of being a truly global force in frame grabbers.

Donal Waide, Director of Sales and Marketing for BitFlow

In order to receive the CE Mark, BitFlow performed an audit of all required safety and electromagnetic compatibility tests at an approved testing facility. The CE Mark ensures compliance of Axion-CL and Cyton-CXP frame grabbers with the most stringent requirements for machine vision technology delivered to European Union customers.

BitFlow's flagship Cyton™ CXP frame grabbers are based on CoaXPress, an asymmetric high speed point to point serial communication standard for the transmission of video, scalable over single or multiple coaxial cables. In addition to leveraging the power of CoaXPress the Cyton-CXP incorporates the Gen 2.0 x8 PCI Express bus interface on its back-end, an advancement that doubles the data rate of the Gen 1.0 bus for the ultimate high speed access to host memory in multi-camera systems, while using the same compact footprint and connectors.

Built on the same half-size x8 PCI Express Gen 2.0 Board as the Cyton, the Axion-CL exploits many of the features that have made the Cyton one of the most successful CXP frame grabbers on the market while using the more cost-effective, highly compatible Camera Link interface. This includes the Cyton's highly optimized DMA engine, StreamSync™ acquisition engine and buffer manager, along with its Timing Sequencer, I/O capabilities and Frame Sequence, all giving machine vision integrators an amazing amount of power at their finger tips, ready to accelerate image processing functions and solve real world vision problems.

For more information, please call 781-932-2900 or visit www.bitflow.com.

BitFlow has been developing reliable, high-performance Frame Grabbers for use in imaging applications since 1993. BitFlow is the leader in Camera Link frame grabbers, building the fastest frame grabbers in the world, with the highest camera/frame grabber densities, triggering performance, and price. With thousands of boards installed throughout the world, into hundreds of imaging applications, BitFlow is dedicated to using this knowledge and experience to provide customers with the best possible image acquisition and application development solutions. BitFlow, located in Woburn, MA, has distributors and resellers located all over the world including Asia, the Americas, and Europe. Visit our website at www.bitflow.com.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bitflow, Inc.. (2019, February 25). BitFlow Secures CE Mark Approval for Axion-CL™ and Cyton-CXP™ Frame Grabbers. AZoOptics. Retrieved on October 30, 2024 from https://www.azooptics.com/News.aspx?newsID=22609.

  • MLA

    Bitflow, Inc.. "BitFlow Secures CE Mark Approval for Axion-CL™ and Cyton-CXP™ Frame Grabbers". AZoOptics. 30 October 2024. <https://www.azooptics.com/News.aspx?newsID=22609>.

  • Chicago

    Bitflow, Inc.. "BitFlow Secures CE Mark Approval for Axion-CL™ and Cyton-CXP™ Frame Grabbers". AZoOptics. https://www.azooptics.com/News.aspx?newsID=22609. (accessed October 30, 2024).

  • Harvard

    Bitflow, Inc.. 2019. BitFlow Secures CE Mark Approval for Axion-CL™ and Cyton-CXP™ Frame Grabbers. AZoOptics, viewed 30 October 2024, https://www.azooptics.com/News.aspx?newsID=22609.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.